|
End-of-day quote
Nasdaq
29/09/2026
|
5-day change | 1st Jan Change | ||
| 15.92 USD | -1.67% |
|
-0.44% | +22.18% |
| 09-30 | Abbott Launches SimpleScreen Blood Test for Colorectal Cancer | MT |
| 09-20 | Freenome, Inc.(NasdaqCM:FRNM) added to S&P TMI Index | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Diagnostics & Testing
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 1.75B | - | - | - | - | - |
| 74.16B | |||||
| 57.39B | |||||
| 47.64B | |||||
| 44.29B | - | - | - | - | - |
| 42.5B |
- Stock Market
- Stocks
- FRNM Stock
- Charts Freenome, Inc.
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
